(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 46.98% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 22.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 22.87%.
Fortress Biotech's revenue in 2026 is $66,161,000.On average, 4 Wall Street analysts forecast FBIO's revenue for 2026 to be $3,230,388,657, with the lowest FBIO revenue forecast at $2,600,322,518, and the highest FBIO revenue forecast at $3,864,706,836.
In 2027, FBIO is forecast to generate $4,545,365,622 in revenue, with the lowest revenue forecast at $4,004,226,939 and the highest revenue forecast at $5,068,233,815.